MASHINIi

Olema Pharmaceuticals, Inc..

OLMA.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Olema Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women's cancers. Their primary focus is on developing therapies that address novel mechanisms of action to improve the standard of care for patients with ...Show More

Ethical Profile

Mixed.

Olema Pharmaceuticals, Inc. (OLMA.US) is dedicated to developing therapies for women's cancers, with its lead product in Phase 3 trials, directly addressing a significant health need. However, reports indicate the company has significant involvement in animal testing as part of its drug development process, which critics point to as conflicting with animal welfare values. Employee sentiment is mixed; while 80% approve of the CEO and 73% would recommend working there, some reviews mention poor management, resource constraints, and stress. The CEO's compensation is $8.13M, and the company reportedly offers 100% employee and dependent health insurance coverage. Concerns have also been raised that its patent strategy could potentially prioritize profit over drug accessibility in low-income countries.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect40
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business-30
-100100
Respect for Cultures & Communities20
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Olema Pharmaceuticals, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

Olema Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing therapies for women's cancers.

1
The company's core business does not involve lending, insuring, moving, or storing money, nor does it offer consumer financial products or services.
2
Therefore, all KPIs related to fair money and economic opportunity, which are designed for financial institutions, are not applicable to Olema Pharmaceuticals.

Fair Pay & Worker Respect

40

Olema Pharmaceuticals covers 100% of medical benefit premiums for employees and their dependents.

1
The company also has an overall employee rating of 4.0 out of 5 stars.
2

Fair Trade & Ethical Sourcing

0

No evidence available to assess Olema Pharmaceuticals, Inc. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

0

The provided articles confirm that Olema Pharmaceuticals, Inc. files annual reports (Form 10-K) and other SEC documents, with filings noted for various dates including March 18, 2025 (for year-end December 31, 2024),

1
March 11, 2024 (for year-end December 31, 2023),
2
and March 9, 2023 (for year-end December 31, 2022).
3
However, the articles do not contain specific, quantifiable data or descriptive facts related to regulatory fines, transparency index scores, whistleblower policies, financial restatements, audit coverage, ESG controversies, complaint resolution times, board independence, anti-corruption policies, or third-party verification of ethical claims.

Kind to Animals

0

The provided articles do not contain specific, quantifiable evidence regarding Olema Pharmaceuticals, Inc.'s (OLMA.US) practices or policies related to animal welfare. While one article states that OLMA has 'Significant Involvement' in animal testing,

1
this is a general qualitative statement and lacks the specific data points required to score any of the KPIs in the rubric, such as the number of animals used, the percentage of products certified cruelty-free, or the extent of investment in animal-free alternatives. Information about FDA regulations and industry-wide trends in alternative testing methods is not attributable to OLMA.US's direct actions or policies.

No War, No Weapons

0

Olema Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing therapies for women's cancers.

1
The company reports 0% revenue from arms or defense contracts, and no investment in peacebuilding initiatives.
2
It does not develop or sell dual-use products, nor does it engage in sales to embargoed regimes.
3
The company has no defense-related lobbying, no exports requiring end-user certification, and no dual-use portfolio to screen.
4
Furthermore, there is no indication of mineral inputs in its products or services, and no procurement from conflict zones.
5
The company's core business model means it has no applicable technology development related to peace tech investment.
6

Planet-Friendly Business

-30

The company has no specific regulatory actions, violations, fines, or compliance issues mentioned in the provided articles.

1

Respect for Cultures & Communities

20

Olema Pharmaceuticals, Inc. recruits 39% of its workforce from local communities.

1

Safe & Smart Tech

0

No evidence available to assess Olema Pharmaceuticals, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No specific, quantifiable evidence was found in the provided articles for any of the Key Performance Indicators related to Zero Waste & Sustainable Products. The articles contain general policy statements, industry trends, and potential regulatory risks, but no concrete data points on waste diversion rates, product recyclability, packaging sustainability, recycled content, waste reduction initiatives, hazardous waste management performance, or any other specific metric for OLMA.US.

Own Olema Pharmaceuticals, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.